AIC
EVH icon

Ameritas Investment Company’s Evolent Health EVH Stock Holding History

Ameritas Investment Company’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-750
Closed -$15.2K – 1133
2021
Q1 		$15.2K Buy
+750
New +$14.3K ﹤0.01% 1386
2019
Q1 		– Sell
-63
Closed -$1K – 1233
2018
Q4 		$1K Buy
+63
New +$1.46K ﹤0.01% 1425

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Ameritas Investment Company's EVH Position: Q2 2021 in Review

Ameritas Investment Company sold out of Evolent Health (EVH) in Q2 2021, closing a stake of 750 shares — an estimated $15.2K sold.

Ameritas Investment Company first reported a position in EVH in Q4 2018 and held it in 2 quarters. The position peaked at $15.2K in Q1 2021. 178 funds tracked by Wall St. Rank hold EVH as of Q2 2021.

  • Ameritas Investment Company reported no remaining Evolent Health position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 750 Evolent Health shares in Q2 2021, an estimated $15.2K.
  • Ameritas Investment Company first reported a position in Evolent Health in Q4 2018 and held it in 2 quarters.
  • Ameritas Investment Company's Evolent Health position peaked at $15.2K in Q1 2021.
  • 178 funds tracked by Wall St. Rank held Evolent Health as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.